2型糖尿病患者血糖波动增加了饮食管理的难度。治疗2型糖尿病的常见药物胰高血糖素样肽-1（GLP-1）受体激动剂、二肽基肽酶-4（DPP-4）抑制剂、二甲双胍类药物、α-葡萄糖苷酶抑制剂、钠-葡萄糖共转运蛋白2（SGLT-2）抑制剂、噻唑烷二酮类药物可以通过多种路径影响食欲。探讨了各类2型糖尿病治疗药物影响食欲的研究进展，为2型糖尿病治疗药物的临床应用提供了参考。

The fluctuation of blood sugar in type 2 diabetes patients increases the difficulty of diet management. Glucagon-like peptide-1 (GLP-1) receptor agonists, dipeptidyl peptidase-4 (DPP-4) inhibitors, metformin, α-glucosidase inhibitors, sodium glucose cotransporter protein 2 (SGLT-2) inhibitors, and thiazolidinedione can affect appetite through multiple paths. This article discusses the research progress of various types of therapeutic drugs for type 2 diabetes affecting appetite, and provided a reference for the clinical application of therapeutic drugs for type 2 diabetes.

R977

国家自然科学基金面上项目（82274486）；四川省中医药管理局项目（2023zd011）